MarketPulse — Real-Time Financial News & Market Analysis

Sportstech Brands denies responsibility for Interactive Strength's poor stock performance, citing operational fundamentals and market conditions. Legal disputes continue in German courts.

Sportstech Brands denies responsibility for TRNR's stock decline and reverse split, citing market conditions instead. Pending legal disputes continue in German courts.

Kyndryl faces class action lawsuit for allegedly issuing false financial statements and maintaining inadequate accounting controls, following a 50% stock drop in February 2026.

Dominion Energy beat earnings expectations and raised capital spending to $64.7B through 2030, driven by surging data center demand from AI and cloud computing expansion.

Vanguard value-focused ETFs outperform flat S&P 500 as sector rotation into financials, industrials, and energy accelerates, offering higher dividend yields.

Institutional investors shift from megacap tech to value stocks, but value valuations now exceed tech despite slower growth, raising concerns about rotation sustainability.

Major investor Anson Funds exits Quantum Computing Inc., liquidating 5.37M shares. Move signals investor concern over company's weak revenue growth and limited commercial traction.

Travel booking stocks fell 22-27% amid AI disruption fears, despite strong earnings. Analysts view the decline as a buying opportunity as companies invest in AI capabilities.

Gold prices surpass $5,000/oz, boosting Newmont's free cash flow to $7.3 billion. Company returns capital via dividends and buybacks while strengthening its balance sheet.

TSMC is critical to global AI infrastructure, manufacturing cutting-edge processors for major tech firms. Its foundry model and advanced capabilities position it to benefit from sustained AI demand.

AMC beat Q4 earnings with $1.29B revenue but stock fell as attendance dropped 10% and free cash flow plummeted 71%, signaling deeper profitability challenges.

SoundHound AI's revenue grew 60% since 2020, but gross margins collapsed from 69% to 49%, raising sustainability concerns despite strong top-line growth.

Oracle faces a class action lawsuit alleging it failed to disclose financial risks tied to its AI infrastructure investments, citing misaligned capital spending and revenue growth.

Class action lawsuit filed against Vistagen Therapeutics for alleged false statements regarding drug trial data. Investors who purchased securities April 2024-December 2025 may be eligible.

Kyndryl faces class action lawsuit alleging false financial statements and internal control weaknesses from August 2024 to February 2026, affecting investors who purchased securities during this period.

BellRing Brands faces class action lawsuit alleging it misrepresented sales growth as organic demand when it actually stemmed from customer inventory restocking following supply chain disruptions.

PomDoctor faces class action lawsuit alleging fraudulent stock promotion scheme involving false statements, insider sales, and market manipulation between October-December 2025.

uniQure faces class action lawsuit alleging misleading statements about FDA study status and BLA timeline delays. Investors who purchased shares Sept-Oct 2025 may be eligible to claim.

REGENXBIO faces class action lawsuit alleging executives made false statements about RGX-111 gene therapy's efficacy and safety, seeking shareholder damages.

Class action lawsuit filed against Picard Medical for alleged securities fraud involving false statements, insider share sales, and social media misinformation to artificially inflate stock price.